Khairul Alam — A deeply concerning trend has emerged in the ongoing measles outbreak across Bangladesh, with healthcare data revealing that a significant percentage of infected infants are under six months of age.
At the Bangladesh Shishu Hospital and Institute in the capital, infants under the age of six months now account for 18 percent of all admitted measles patients, sparking urgent concern among epidemiologists and pediatricians over declining maternal immunity levels.
Traditionally, public health strategies operated under the widely accepted medical consensus that newborns inherit strong maternal antibodies that shield them from diseases like measles during their first few months of life.
This natural protection, reinforced by breastfeeding, forms the scientific basis for the national Expanded Programme on Immunization (EPI), which schedules the first dose of the measles-rubella vaccine at nine months of age.
However, recent outbreaks have shattered these assumptions, revealing a growing vulnerability among much younger cohorts.
National Toll and Statistical Breakthroughs
According to data compiled by the integrated control room of the Directorate General of Health Services (DGHS) as of Saturday, July 18, 2026, the country is facing an aggressive resurgence of the viral disease.
A total of 116,710 patients exhibiting measles-like symptoms have sought care at public and private hospitals nationwide this year. Among them, 14,318 cases have been laboratory-confirmed.
The outbreak has taken a heavy toll; 689 individuals have died with measles symptoms, while 95 fatalities have been explicitly confirmed as measles deaths.
The DGHS reported four additional symptomatic deaths just yesterday.
While centralized DGHS statistics lack specific age-stratified breakdowns regarding vulnerability and mortality rates, records from the Bangladesh Shishu Hospital and Institute provide a clearer window into the crisis.
Between January and July 18, 2026, the premier pediatric facility admitted 1,770 children with measles symptoms arriving from 53 different districts. Remarkably, 334 of these patients were under six months old, while 192 were above the age of five.
Out of 368 laboratory-confirmed measles cases within the institute, 66 were infants under the age of six months, and 36 were children over five years old.
Shifting Vaccine Dynamics and Expert Warnings
Recognizing that younger infants were falling ill, the government expanded its recent national Measles-Rubella (MR) vaccination campaign to lower the temporary eligibility age to six months.
Yet, the latest data shows that the virus is hitting demographics entirely outside this campaign window—specifically infants under six months and children older than five, who combined make up roughly 28 percent of the hospital’s caseload.
Prominent medical experts believe this shift demands immediate scientific investigation into community immunity structures.
“Maternal antibodies and breast milk have historically protected infants during their earliest months. However, the phenomenon of infants under six months falling victim to measles raises serious questions about the current state of this protective barrier. The time has come for an in-depth investigation into children’s changing immune profiles.”
— Professor Abid Hossain Mollah, Renowned Pediatrician and Former Head of the Department of Pediatrics at Dhaka Medical College
Public health experts stress that if maternal antibodies are waning sooner than expected, national immunization schedules and maternal vaccination strategies may require a major overhaul to prevent the virus from exploiting this critical window of vulnerability.